Teysuno (gimeracil oteracil monopotassium tegafur): Reviews and patient testimonials

/static/themes-v3/default/images/default/opinion/traitement/intro.jpg?1720004028

Medication indications

Teysuno 15mg/4.35mg/11.8mg hard capsules

Teysuno is indicated in adults for the treatment of advanced gastric cancer when given in combination with cisplatin.

Teysuno 20mg/5.8mg/15.8mg hard capsules

Teysuno is indicated in adults for the treatment of advanced gastric cancer when given in combination with cisplatin.


Route of administration: Oral
Molecule: gimeracil, oteracil monopotassium, tegafur

Patients' opinions on Teysuno

In brief

General satisfaction level: Be the first to evaluate

Treatment's effectiveness: Be the first to evaluate

Ease of use: Be the first to evaluate

Adherence to prescription: Be the first to evaluate

Detected side effects: Be the first to evaluate

Improvement in the quality of life: Be the first to evaluate

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Never
10 = Always

1 = Not at all important
10 = Extremely important

1 = Not at all satisfied
10 = Extremely satisfied

Tips and advice of the community

Join Carenity and be the first to give your opinion on this medication.